RNA-dependent RNA polymerase (RdRp) inhibitors: the current landscape and repurposing for the COVID-19 pandemic
出版年份 2021 全文链接
标题
RNA-dependent RNA polymerase (RdRp) inhibitors: the current landscape and repurposing for the COVID-19 pandemic
作者
关键词
COVID-19, RNA virus, SARS-CoV-2, RNA-dependent RNA polymerase (RdRp), Nucleoside/non-nucleoside analogue inhibitor
出版物
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume -, Issue -, Pages 113201
出版商
Elsevier BV
发表日期
2021-01-22
DOI
10.1016/j.ejmech.2021.113201
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2
- (2020) Xi Xu et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
- (2020) Kimiyasu Shiraki et al. PHARMACOLOGY & THERAPEUTICS
- Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virus
- (2020) Steven S. Good et al. PLoS One
- Cryo-EM structure of the respiratory syncytial virus RNA polymerase
- (2020) Dongdong Cao et al. Nature Communications
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019‐nCoV Infection
- (2020) Yin‐Xiao Du et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The potential chemical structure of anti‐SARS‐CoV‐2 RNA‐dependent RNA polymerase
- (2020) Jrhau Lung et al. JOURNAL OF MEDICAL VIROLOGY
- SARS-CoV-2 RNA polymerase as target for antiviral therapy
- (2020) Luigi Buonaguro et al. Journal of Translational Medicine
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Structure of replicating SARS-CoV-2 polymerase
- (2020) Hauke S. Hillen et al. NATURE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure of the RNA-dependent RNA polymerase from COVID-19 virus
- (2020) Yan Gao et al. SCIENCE
- Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
- (2020) Wanchao Yin et al. SCIENCE
- An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
- (2020) Timothy P. Sheahan et al. Science Translational Medicine
- Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting
- (2020) S. Hughes et al. CLINICAL MICROBIOLOGY AND INFECTION
- The Development of Coronavirus 3C-Like Protease (3CLpro) Inhibitors from 2010 to 2020
- (2020) Yuzhi Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Ribavirin therapy for severe COVID-19: a retrospective cohort study
- (2020) Song Tong et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19
- (2020) Massimo Tempestilli et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Vaccine development and therapeutic design for 2019‐nCoV/SARS‐CoV‐2: Challenges and chances
- (2020) Mahnaz Ghaebi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
- (2020) Abdo A. Elfiky LIFE SCIENCES
- Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
- (2020) Brandi N. Williamson et al. NATURE
- Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency
- (2020) Thamina Acter et al. SCIENCE OF THE TOTAL ENVIRONMENT
- Nucleocapsid Structure of Negative Strand RNA Virus
- (2020) Ming Luo et al. Viruses-Basel
- Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment
- (2020) Victoria C. Yan et al. ACS Medicinal Chemistry Letters
- Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic
- (2020) Rodrigo Jácome et al. Scientific Reports
- A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir
- (2020) Chengyuan Liang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and Anti-HCV Activity of Sugar-Modified Guanosine Analogues: Discovery of AL-611 as an HCV NS5B Polymerase Inhibitor for the Treatment of Chronic Hepatitis C
- (2020) Guangyi Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- COVID-19 vaccine trials should seek worthwhile efficacy
- (2020) Philip Krause et al. LANCET
- Packaging of Genomic RNA in Positive-Sense Single-Stranded RNA Viruses: A Complex Story
- (2019) Mauricio Comas-Garcia Viruses-Basel
- Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis
- (2019) Niels C Pedersen et al. JOURNAL OF FELINE MEDICINE AND SURGERY
- JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1
- (2019) Stefan Zeuzem et al. HEPATOLOGY
- Ribavirin: pharmacology, multiple modes of action and possible future perspectives
- (2019) Kristina Nyström et al. Future Virology
- Synthesis and Anti-HCV Activities of 4′-Fluoro-2′-Substituted Uridine Triphosphates and Nucleotide Prodrugs: Discovery of 4′-Fluoro-2′-C-methyluridine 5′-Phosphoramidate Prodrug (AL-335) for the Treatment of Hepatitis C Infection
- (2019) Guangyi Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
- (2019) Egor Tchesnokov et al. Viruses-Basel
- Advances in respiratory virus therapeutics – A meeting report from the 6th isirv Antiviral Group conference
- (2019) John H. Beigel et al. ANTIVIRAL RESEARCH
- Design, Synthesis, and Anti-RNA Virus Activity of 6′-Fluorinated-Aristeromycin Analogues
- (2019) Ji-seong Yoon et al. JOURNAL OF MEDICINAL CHEMISTRY
- Small-Molecule Antiviral β-D-N4-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance
- (2019) Maria L. Agostini et al. JOURNAL OF VIROLOGY
- Conservative transcription in three steps visualized in a double-stranded RNA virus
- (2019) Yanxiang Cui et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Anti-hepatitis-C virus activity and QSAR study of certain thiazolidinone and thiazolotriazine derivatives as potential NS5B polymerase inhibitors
- (2019) Ghaneya S. Hassan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Galidesivir limits Rift Valley fever virus infection and disease in Syrian golden hamsters
- (2018) Jonna B. Westover et al. ANTIVIRAL RESEARCH
- Synthesis and Biological Characterization of Aryl Uracil Inhibitors of Hepatitis C Virus NS5B Polymerase: Discovery of ABT-072, a trans-Stilbene Analog with Good Oral Bioavailability
- (2018) John T. Randolph et al. JOURNAL OF MEDICINAL CHEMISTRY
- The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies
- (2018) B.G. Murphy et al. VETERINARY MICROBIOLOGY
- RNA Dependent RNA Polymerases: Insights from Structure, Function and Evolution
- (2018) Sangita Venkataraman et al. Viruses-Basel
- Recombinant RNA-Dependent RNA Polymerase Complex of Ebola Virus
- (2018) Egor P. Tchesnokov et al. Scientific Reports
- Influenza A Virus Infection Causes Chronic Lung Disease Linked to Sites of Active Viral RNA Remnants
- (2018) Shamus P. Keeler et al. JOURNAL OF IMMUNOLOGY
- Safety, tolerability, and pharmacokinetics of AL-335 in healthy volunteers and hepatitis C virus-infected subjects
- (2018) Matthew W. McClure et al. PLoS One
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- (2018) Robert W Finberg et al. JOURNAL OF INFECTIOUS DISEASES
- The ProTide Prodrug Technology: Where Next?
- (2018) Ashwag S. Alanazi et al. ACS Medicinal Chemistry Letters
- Discovery and preclinical development of dasabuvir for the treatment of hepatitis C infection
- (2017) Mohamed El Kassas et al. Expert Opinion on Drug Discovery
- Are RNA Viruses Candidate Agents for the Next Global Pandemic? A Review
- (2017) R Carrasco-Hernandez et al. ILAR JOURNAL
- Evolution and Emergence of Pathogenic Viruses: Past, Present, and Future
- (2017) Mohammad K. Parvez et al. INTERVIROLOGY
- Phase 1 study assessing the safety, pharmacokinetics, and antiviral activity of CC-31244, a pan-genotypic, potent non-nucleoside NS5B polymerase inhibitor for the treatment of hepatitis C virus infection
- (2017) S. Lee et al. JOURNAL OF HEPATOLOGY
- Virucidal Activity of World Health Organization–Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses
- (2017) Anindya Siddharta et al. JOURNAL OF INFECTIOUS DISEASES
- AIDS, Avian flu, SARS, MERS, Ebola, Zika… what next?
- (2017) Leslie A. Reperant et al. VACCINE
- Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae
- (2017) André C. Ferreira et al. Scientific Reports
- Evaluation of Sofosbuvir (β-D-2′-deoxy-2′-α-fluoro-2′-β-C-methyluridine) as an inhibitor of Dengue virus replication #
- (2017) Hong-Tao Xu et al. Scientific Reports
- Signatures of Nucleotide Analog Incorporation by an RNA-Dependent RNA Polymerase Revealed Using High-Throughput Magnetic Tweezers
- (2017) David Dulin et al. Cell Reports
- Persistent RNA virus infections: do PAMPS drive chronic disease?
- (2017) Mary K McCarthy et al. Current Opinion in Virology
- Origin and Evolution of RNA-Dependent RNA Polymerase
- (2017) Savio T. de Farias et al. Frontiers in Genetics
- CC-31244, A Novel, Pan-Genotypic, Potent NS5B Non-Nucleoside Polymerase Inhibitor for the Treatment of Chronic Hepatitis C
- (2016) I. Jacobson et al. JOURNAL OF HEPATOLOGY
- Discovery of 1-((2R,4aR,6R,7R,7aR)-2-Isopropoxy-2-oxidodihydro-4H,6H-spiro[furo[3,2-d][1,3,2]dioxaphosphinine-7,2′-oxetan]-6-yl)pyrimidine-2,4(1H,3H)-dione (JNJ-54257099), a 3′-5′-Cyclic Phosphate Ester Prodrug of 2′-Deoxy-2′-Spirooxetane Uridine Triphosphate Useful for HCV Inhibition
- (2016) Tim H. M. Jonckers et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural basis of an essential interaction between influenza polymerase and Pol II CTD
- (2016) Maria Lukarska et al. NATURE
- Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with Chronic Hepatitis C Genotype 1 Infection and Prior Null Response: The Randomized DYNAMO 1 and DYNAMO 2 Studies
- (2016) Heiner Wedemeyer et al. PLoS One
- Biochemical Effect of Resistance Mutations against Synergistic Inhibitors of RSV RNA Polymerase
- (2016) Jerome Deval et al. PLoS One
- Zika Virus Disrupts Phospho-TBK1 Localization and Mitosis in Human Neuroepithelial Stem Cells and Radial Glia
- (2016) Marco Onorati et al. Cell Reports
- Characterization of the activity of 2′-C-methylcytidine against dengue virus replication
- (2015) Jin-Ching Lee et al. ANTIVIRAL RESEARCH
- Ebola virus dynamics in mice treated with favipiravir
- (2015) Vincent Madelain et al. ANTIVIRAL RESEARCH
- Phosphorylation at the N-terminal finger subdomain of a viral RNA-dependent RNA polymerase
- (2015) Sergio Hernández et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Structure of the L Protein of Vesicular Stomatitis Virus from Electron Cryomicroscopy
- (2015) Bo Liang et al. CELL
- Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor Sofosbuvir
- (2015) Brian J. Kirby et al. CLINICAL PHARMACOKINETICS
- RNA Viruses: RNA Roles in Pathogenesis, Coreplication and Viral Load
- (2015) Palmiro Poltronieri et al. CURRENT GENOMICS
- The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C
- (2015) Ivan Gentile et al. Expert Opinion on Drug Discovery
- Beclabuvir for the treatment of hepatitis C
- (2015) Ivan Gentile et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Fixed-Dose Combination Therapy With Daclatasvir, Asunaprevir, and Beclabuvir for Noncirrhotic Patients With HCV Genotype 1 Infection
- (2015) Fred Poordad et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- LP27 : ACH-3422, A novel nucleotide prodrug inhibitor of HCV NS5B polymerase
- (2015) E. Gane et al. JOURNAL OF HEPATOLOGY
- Discovery of 4′-Chloromethyl-2′-deoxy-3′,5′-di-O-isobutyryl-2′-fluorocytidine (ALS-8176), A First-in-Class RSV Polymerase Inhibitor for Treatment of Human Respiratory Syncytial Virus Infection
- (2015) Guangyi Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Crystal structure of the RNA-dependent RNA polymerase from influenza C virus
- (2015) Narin Hengrung et al. NATURE
- Discovery of an essential nucleotidylating activity associated with a newly delineated conserved domain in the RNA polymerase-containing protein of all nidoviruses
- (2015) Kathleen C. Lehmann et al. NUCLEIC ACIDS RESEARCH
- RNA-Dependent RNA Polymerases of Picornaviruses: From the Structure to Regulatory Mechanisms
- (2015) Cristina Ferrer-Orta et al. Viruses-Basel
- Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication
- (2015) Olivier Reynard et al. Viruses-Basel
- Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine Triphosphate
- (2015) Jerome Deval et al. PLoS Pathogens
- Preclinical Characterization of BMS-791325, an Allosteric Inhibitor of Hepatitis C Virus NS5B Polymerase
- (2014) Julie A. Lemm et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and Safety of Faldaprevir, Deleobuvir, and Ribavirin in Treatment-Naive Patients with Chronic Hepatitis C Virus Infection and Advanced Liver Fibrosis or Cirrhosis
- (2014) Stefan Zeuzem et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity and Resistance Profile of Dasabuvir, a Nonnucleoside Hepatitis C Virus Polymerase Inhibitor
- (2014) Warren Kati et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Analysis of the hepatitis C viral kinetics during administration of two nucleotide analogues: sofosbuvir (GS-7977) and GS-0938
- (2014) Jeremie Guedj et al. ANTIVIRAL THERAPY
- Common and unique features of viral RNA-dependent polymerases
- (2014) Aartjan J. W. te Velthuis CELLULAR AND MOLECULAR LIFE SCIENCES
- Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus
- (2014) Ivan Gentile et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- GS-9669: a novel non-nucleoside inhibitor of viral polymerase for the treatment of hepatitis C virus infection
- (2014) Ivan Gentile et al. Expert Review of Anti-Infective Therapy
- Effect of quantum nuclear motion on hydrogen bonding
- (2014) Ross H. McKenzie et al. JOURNAL OF CHEMICAL PHYSICS
- A randomized, placebo-controlled study of the NS5B inhibitor beclabuvir with peginterferon/ribavirin for HCV genotype 1
- (2014) H. Tatum et al. JOURNAL OF VIRAL HEPATITIS
- Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430
- (2014) Travis K. Warren et al. NATURE
- Favipiravir (T-705), a novel viral RNA polymerase inhibitor
- (2013) Yousuke Furuta et al. ANTIVIRAL RESEARCH
- Chutes and ladders in hepatitis C nucleoside drug development
- (2013) Steven J. Coats et al. ANTIVIRAL RESEARCH
- Potent Inhibition of the C–P Lyase Nucleosidase PhnI by Immucillin-A Triphosphate
- (2013) Siddhesh S. Kamat et al. BIOCHEMISTRY
- A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1
- (2013) Eric Lawitz et al. JOURNAL OF HEPATOLOGY
- Discovery of a Novel Series of Potent Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B
- (2013) Ryan C. Schoenfeld et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of Hepatitis C Virus (HCV) Replication by Specific RNA Aptamers against HCV NS5B RNA Replicase
- (2013) C. H. Lee et al. JOURNAL OF VIROLOGY
- First-in-Human Study of the Pharmacokinetics and Antiviral Activity of IDX375, a Novel Nonnucleoside Hepatitis C Virus Polymerase Inhibitor
- (2012) J. de Bruijne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Preclinical Characterization of GS-9669, a Thumb Site II Inhibitor of the Hepatitis C Virus NS5B Polymerase
- (2012) M. Fenaux et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics, Safety, and Tolerability of GS-9851, a Nucleotide Analog Polymerase Inhibitor for Hepatitis C Virus, following Single Ascending Doses in Healthy Subjects
- (2012) Jill Denning et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhibition of norovirus replication by the nucleoside analogue 2′-C-methylcytidine
- (2012) J. Rocha-Pereira et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Discovery of 4′-azido-2′-deoxy-2′-C-methyl cytidine and prodrugs thereof: A potent inhibitor of Hepatitis C virus replication
- (2012) Magnus Nilsson et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Identification of aryl dihydrouracil derivatives as palm initiation site inhibitors of HCV NS5B polymerase
- (2012) Yaya Liu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study
- (2012) Fatimah S Dawood et al. LANCET INFECTIOUS DISEASES
- Tegobuvir (GS-9190) potency against HCV chimeric replicons derived from consensus NS5B sequences from genotypes 2b, 3a, 4a, 5a, and 6a
- (2012) Kelly A. Wong et al. VIROLOGY
- Biochemical Study of the Comparative Inhibition of Hepatitis C Virus RNA Polymerase by VX-222 and Filibuvir
- (2011) Guanghui Yi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Hepatitis C viral kinetics with the nucleoside polymerase inhibitor mericitabine (RG7128)
- (2011) Jeremie Guedj et al. HEPATOLOGY
- RNA virus replication, transcription and recombination
- (2011) K. Andrew White et al. RNA Biology
- Combination of α-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo
- (2010) Jinhong Chang et al. ANTIVIRAL RESEARCH
- Inhibitors of hepatitis C virus polymerase: Synthesis and characterization of novel 2-oxy-6-fluoro-N-((S)-1-hydroxy-3-phenylpropan-2-yl)-benzamides
- (2010) Cliff C. Cheng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Mechanism of Activation of PSI-7851 and Its Diastereoisomer PSI-7977
- (2010) Eisuke Murakami et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- 2013 ANTIVIRAL ACTIVITY, PHARMACOKINETICS AND SAFETY OF IDX184 IN COMBINATION WITH PEGYLATED INTERFERON (PEGIFN) AND RIBAVIRIN (RBV) IN TREATMENT-NAIVE HCV GENOTYPE 1-INFECTED SUBJECTS
- (2010) J. Lalezari et al. JOURNAL OF HEPATOLOGY
- RG7128 Alone or in Combination with Pegylated Interferon‐α2a and Ribavirin Prevents Hepatitis C Virus (HCV) Replication and Selection of Resistant Variants in HCV‐Infected Patients
- (2010) Sophie Le Pogam et al. JOURNAL OF INFECTIOUS DISEASES
- Discovery of a β-d-2′-Deoxy-2′-α-fluoro-2′-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus
- (2010) Michael J. Sofia et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of (7R)-14-Cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl) amino}-7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine-11-carboxylic Acid (MK-3281), a Potent and Orally Bioavailable Finger-Loop Inhibitor of the Hepatitis C Virus NS5B Polymerase
- (2010) Frank Narjes et al. JOURNAL OF MEDICINAL CHEMISTRY
- Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial
- (2010) Edward J Gane et al. LANCET
- Preclinical Characterization of PF-00868554, a Potent Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase
- (2009) S. T. Shi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Substituted benzothiadizine inhibitors of Hepatitis C virus polymerase
- (2009) Antony N. Shaw et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Antimicrobial Strategies
- (2009) Jerome Deval DRUGS
- Severe Hepatocellular Injury With Apoptosis Induced by a Hepatitis C Polymerase Inhibitor
- (2009) Ariel Feldstein et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- 940 SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE HCV POLYMERASE INHIBITOR VCH-222 FOLLOWING SINGLE DOSE ADMINISTRATION IN HEALTHY VOLUNTEERS AND ANTIVIRAL ACTIVITY IN HCV-INFECTED INDIVIDUALS
- (2009) C. Cooper et al. JOURNAL OF HEPATOLOGY
- 1055 ANTIVIRAL ACTIVITY OF ANA598, A POTENT NON- NUCLEOSIDE POLYMERASE INHIBITOR, IN CHRONIC HEPATITIS C PATIENTS
- (2009) E. Lawitz et al. JOURNAL OF HEPATOLOGY
- 1054 SAFETY, PHARMACOKINETICS AND ANTIVIRAL EFFECT OF BI 207127, A NOVEL HCV RNA POLYMERASE INHIBITOR, AFTER 5 DAYS ORAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C
- (2009) D. Larrey et al. JOURNAL OF HEPATOLOGY
- 935 IDENTIFICATION AND CHARACTERIZATION OF VCH-222, A NOVEL POTENT AND SELECTIVE NON-NUCLEOSIDE HCV POLYMERASE INHIBITOR
- (2009) J. Bedard et al. JOURNAL OF HEPATOLOGY
- Evaluation of VCH-759 monotherapy in hepatitis C infection
- (2009) Curtis Cooper et al. JOURNAL OF HEPATOLOGY
- Discovery of (R)-6-Cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a Potent and Orally Available Hepatitis C Virus Polymerase Inhibitor
- (2009) Hui Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA
- (2009) Yoshiko Maida et al. NATURE
- Molecular Mechanism of Hepatitis C Virus Replicon Variants with Reduced Susceptibility to a Benzofuran Inhibitor, HCV-796
- (2008) A. Y. M. Howe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tetracyclic indole inhibitors of hepatitis C virus NS5B-polymerase
- (2008) Ian Stansfield et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity In Vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus
- (2008) Norman M. Kneteman et al. HEPATOLOGY
- 854 RESULTS OF A SAFETY, TOLERABILITY AND PHARMACOKINETIC PHASE I STUDY OF VCH-916, A NOVEL POLYMERASE INHIBITOR FOR HCV, FOLLOWING SINGLE ASCENDING DOSES IN HEALTHY VOLUNTEERS
- (2008) L. Proulx et al. JOURNAL OF HEPATOLOGY
- 67 POTENT ANTIVIRAL ACTIVITY OF SECOND GENERATION NUCLEOSIDE INHIBITORS, IDX102 AND IDX184, IN HCV-INFECTED CHIMPANZEES
- (2008) D.N. Standring et al. JOURNAL OF HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now